Takeda gets Japan’s approval for $62 billion Shire purchase


(Reuters) – Takeda Pharmaceutical Co Ltd <4502.T> said on Thursday Japan’s Fair Trade Commission had approved its $62 billion acquisition of Shire Plc <SHP.L>, bringing the Japanese firm closer to sealing a deal that will make it a global top 10 drugmaker.

The deal, which will be the largest overseas purchase by a Japanese company, has already received unconditional clearance from regulators in the United States, Brazil and China.

(Reporting by Shashwat Awasthi in Bengaluru)

FILE PHOTO: Shire branding is seen outside their offices in Dublin, Ireland, April 25, 2018. REUTERS/Clodagh Kilcoyne